New treatments for malignant gliomas: Careful evaluation and cautious optimism required

被引：15

作者：

Gilbert, MR ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2006年 / 144卷 / 05期

关键词：

D O I：

10.7326/0003-4819-144-5-200603070-00015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：371 / 373

页数：3

共 18 条

[1]

Afra D, 2002, LANCET, V359, P1011

[2] RECURSIVE PARTITIONING ANALYSIS OF PROGNOSTIC FACTORS IN 3 RADIATION-THERAPY ONCOLOGY GROUP MALIGNANT GLIOMA TRIALS [J].

CURRAN, WJ ;

SCOTT, CB ;

HORTON, J ;

NELSON, JS ;

WEINSTEIN, AS ;

FISCHBACH, AJ ;

CHANG, CH ;

ROTMAN, M ;

ASBELL, SO ;

KRISCH, RE ;

NELSON, DF .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (09) :704-710

[3]

FINE HA, 1993, CANCER, V71, P2585, DOI 10.1002/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO

[4]

2-S

[5] Neuro-oncology clinical trials: Promise and pitfalls [J].

Gilbert, MR .

ANNALS OF ONCOLOGY, 2001, 12 (02) :149-150

[6] Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma [J].

Grossman, SA ;

Wharam, M ;

Sheidler, V ;

Kleinberg, L ;

Zeltzman, M ;

Yue, N ;

Piantadosi, S .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) :2596-2603

[7] Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394 [J].

Grossman, SA ;

O'Neill, A ;

Grunnet, M ;

Mehta, M ;

Pearlman, JL ;

Wagner, H ;

Gilbert, M ;

Newton, HB ;

Hellman, R .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1485-1491

[8] Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide [J].

Hegi, ME ;

Diserens, AC ;

Godard, S ;

Dietrich, PY ;

Regli, L ;

Ostermann, S ;

Otten, P ;

Van Melle, G ;

de Tribolet, N ;

Stupp, R .

CLINICAL CANCER RESEARCH, 2004, 10 (06) :1871-1874

[9] MGMT gene silencing and benefit from temozolomide in glioblastoma [J].

Hegi, ME ;

Diserens, A ;

Gorlia, T ;

Hamou, M ;

de Tribolet, N ;

Weller, M ;

Kros, JM ;

Hainfellner, JA ;

Mason, W ;

Mariani, L ;

Bromberg, JEC ;

Hau, P ;

Mirimanoff, RO ;

Cairncross, JG ;

Janzer, RC ;

Stupp, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :997-1003

[10] A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival [J].

Lacroix, M ;

Abi-Said, D ;

Fourney, DR ;

Gokaslan, ZL ;

Shi, WM ;

DeMonte, F ;

Lang, FF ;

McCutcheon, IE ;

Hassenbusch, SJ ;

Holland, E ;

Hess, K ;

Michael, C ;

Miller, D ;

Sawaya, R .

JOURNAL OF NEUROSURGERY, 2001, 95 (02) :190-198

← 1 2 →